WHO WE ARE

Aprea Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53.

Explore Partnership Opportunities

3box_1APR-246

Strong synergy with other anticancer drugs

Learn More

cad_greenp53

Tumor suppressor and key to cancer treatment

Learn More

news_blueLatest News

Aprea has four ongoing clinical trials to evaluate APR-246 in solid and liquid tumors

Learn More

PARTNERING

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt.

Get Investor Information